<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31186084</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1976-670X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>52</Volume>
            <Issue>7</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>BMB reports</Title>
          <ISOAbbreviation>BMB Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>mTOR signalling pathway - A root cause for idiopathic autism?</ArticleTitle>
        <Pagination>
          <StartPage>424</StartPage>
          <EndPage>433</EndPage>
          <MedlinePgn>424-433</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Autism spectrum disorder (ASD) is a complex neurodevelopmental monogenic disorder with a strong genetic influence. Idiopathic autism could be defined as a type of autism that does not have a specific causative agent. Among signalling cascades, mTOR signalling pathway plays a pivotal role not only in cell cycle, but also in protein synthesis and regulation of brain homeostasis in ASD patients. The present review highlights, underlying mechanism of mTOR and its role in altered signalling cascades as a triggering factor in the onset of idiopathic autism. Further, this review discusses how distorted mTOR signalling pathway stimulates truncated translation in neuronal cells and leads to downregulation of protein synthesis at dendritic spines of the brain. This review concludes by suggesting downstream regulators such as p70S6K, eIF4B, eIF4E of mTOR signalling pathway as promising therapeutic targets for idiopathic autistic individuals. [BMB Reports 2019; 52(7): 424-433].</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ganesan</LastName>
            <ForeName>Harsha</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, Tamil Nadu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Balasubramanian</LastName>
            <ForeName>Venkatesh</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, Tamil Nadu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Iyer</LastName>
            <ForeName>Mahalaxmi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore 641043, Tamil Nadu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Venugopal</LastName>
            <ForeName>Anila</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, Tamil Nadu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Subramaniam</LastName>
            <ForeName>Mohana Devi</ForeName>
            <Initials>MD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics and Molecular Biology, Vision Research Foundation, Sankara Nethralaya, Chennai 600006, Tamil Nadu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cho</LastName>
            <ForeName>Ssang-Goo</ForeName>
            <Initials>SG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul 05029, Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vellingiri</LastName>
            <ForeName>Balachandar</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, Tamil Nadu, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMB Rep</MedlineTA>
        <NlmUniqueID>101465334</NlmUniqueID>
        <ISSNLinking>1976-6696</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001321" MajorTopicYN="N">Autistic Disorder</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement><b>CONFLICTS OF INTEREST</b>. The authors have no conflicting interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>5</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>6</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31186084</ArticleId>
        <ArticleId IdType="pmc">PMC6675248</ArticleId>
        <ArticleId IdType="pii">4654</ArticleId>
        <ArticleId IdType="doi">10.5483/BMBRep.2019.52.7.137</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Al-Zahrani A. Prevalence and clinical characteristics of autism spectrum disorders in school-age children in Taif-KSA. Int J Med Sci Public Health. 2013;2:578–582. doi: 10.5455/ijmsph.2013.160420133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5455/ijmsph.2013.160420133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gilbert J, Man HY. Fundamental elements in autism: from neurogenesis and neurite growth to synaptic plasticity. Front Cell Neurosci. 2017;11:359. doi: 10.3389/fncel.2017.00359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2017.00359</ArticleId>
            <ArticleId IdType="pmc">PMC5701944</ArticleId>
            <ArticleId IdType="pubmed">29209173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang YH, Wang Y, Xiu X, Choy KW, Pursley AN, Cheung SW. Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era. Crit Rev Clin Lab Sci. 2014;51:249–262. doi: 10.3109/10408363.2014.910747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/10408363.2014.910747</ArticleId>
            <ArticleId IdType="pmc">PMC5937018</ArticleId>
            <ArticleId IdType="pubmed">24878448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mattila ML, Kielinen M, Linna SL, et al.  Autism spectrum disorders according to DSM-IV-TR and comparison with DSM-5 draft criteria: an epidemiological study. J Am Acad Child Adolesc Psychiatry. 2011;50:583–592. doi: 10.1016/j.jaac.2011.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaac.2011.04.001</ArticleId>
            <ArticleId IdType="pubmed">21621142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harker CM, Stone WL. Comparison of the Diagnostic Criteria for Autism Spectrum Disorder Across DSM-5, DSM-IV-TR, 2 and the Individuals with Disabilities Act (IDEA) 3 Definition of Autism. 2014:1–6.</Citation>
        </Reference>
        <Reference>
          <Citation>King BH, Navot N, Bernier R, Webb SJ. Update on diagnostic classification in autism. Curr Opin Psychiatry. 2014;27:105. doi: 10.1097/YCO.0000000000000040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/YCO.0000000000000040</ArticleId>
            <ArticleId IdType="pmc">PMC4929984</ArticleId>
            <ArticleId IdType="pubmed">24441420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howes OD, Rogdaki M, Findon JL, et al.  Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol. 2018;32:3–29. doi: 10.1177/0269881117741766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0269881117741766</ArticleId>
            <ArticleId IdType="pmc">PMC5805024</ArticleId>
            <ArticleId IdType="pubmed">29237331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Venugopal A, Chandran M, Eruppakotte N, Kizhakkillach S, Breezevilla SC, Vellingiri B. Monogenic diseases in India. Mutat Res. 2018;776:23–31. doi: 10.1016/j.mrrev.2018.03.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mrrev.2018.03.003</ArticleId>
            <ArticleId IdType="pubmed">29807575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicolini C, Ahn Y, Michalski B, Rho JM, Fahnestock M. Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol Commun. 2015;3:3. doi: 10.1186/s40478-015-0184-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40478-015-0184-4</ArticleId>
            <ArticleId IdType="pmc">PMC4307681</ArticleId>
            <ArticleId IdType="pubmed">25627160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The familial risk of autism. JAMA. 2014;311:1770–1777. doi: 10.1001/jama.2014.4144.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2014.4144</ArticleId>
            <ArticleId IdType="pmc">PMC4381277</ArticleId>
            <ArticleId IdType="pubmed">24794370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berko ER, Suzuki M, Beren F, et al.  Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder. PLoS Genet. 2014;10:e1004402. doi: 10.1371/journal.pgen.1004402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1004402</ArticleId>
            <ArticleId IdType="pmc">PMC4038484</ArticleId>
            <ArticleId IdType="pubmed">24875834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>St-Hilaire S, Ezike VO, Stryhn H, Thomas MA. An ecological study on childhood autism. Int J of Health Geogr. 2012;11:44. doi: 10.1186/1476-072X-11-44.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1476-072X-11-44</ArticleId>
            <ArticleId IdType="pmc">PMC3504530</ArticleId>
            <ArticleId IdType="pubmed">23051560</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tordjman S, Davlantis KS, Georgieff N, et al.  Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives. Front Pediatr. 2015;3:1. doi: 10.3389/fped.2015.00001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fped.2015.00001</ArticleId>
            <ArticleId IdType="pmc">PMC4337381</ArticleId>
            <ArticleId IdType="pubmed">25756039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry. 2013;70:71–77. doi: 10.1001/jamapsychiatry.2013.266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2013.266</ArticleId>
            <ArticleId IdType="pmc">PMC4019010</ArticleId>
            <ArticleId IdType="pubmed">23404082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Subramanian M, Timmerman CK, Schwartz JL, Pham DL, Meffert MK. Characterizing autism spectrum disorders by key biochemical pathways. Front Neurosci. 2015;9:313. doi: 10.3389/fnins.2015.00313.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2015.00313</ArticleId>
            <ArticleId IdType="pmc">PMC4586332</ArticleId>
            <ArticleId IdType="pubmed">26483618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hutsler JJ, Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 2010;1309:83–94. doi: 10.1016/j.brainres.2009.09.120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2009.09.120</ArticleId>
            <ArticleId IdType="pubmed">19896929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Horgusluoglu E, Nudelman K, Nho K, Saykin AJ. Adult neurogenesis and neurodegenerative diseases: A systems biology perspective. Am J Med Genet B Neuropsychiatr Genet. 2017;174:93–112. doi: 10.1002/ajmg.b.32429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.b.32429</ArticleId>
            <ArticleId IdType="pmc">PMC4987273</ArticleId>
            <ArticleId IdType="pubmed">26879907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Betizeau M, Dehay C. From stem cells to comparative corticogenesis: a bridge too far? Stem cell Investing. 2016;3:39. doi: 10.21037/sci.2016.08.02.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/sci.2016.08.02</ArticleId>
            <ArticleId IdType="pmc">PMC5014852</ArticleId>
            <ArticleId IdType="pubmed">27668246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osborne LR. Caveat mTOR: aberrant signaling disrupts corticogenesis. J Clin Invest. 2010;120:1392–1395. doi: 10.1172/JCI43030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI43030</ArticleId>
            <ArticleId IdType="pmc">PMC2860937</ArticleId>
            <ArticleId IdType="pubmed">20424320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gatto CL, Broadie K. Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci. 2010;2:4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3059704</ArticleId>
            <ArticleId IdType="pubmed">21423490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zatkova M, Bakos J, Hodosy J, Ostatnikova D. Synapse alterations in autism: Review of animal model findings. Biomed Pap Med Fac Uni Palacky Olomouc Czech Repub. 2016;160:201–210. doi: 10.5507/bp.2015.066.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5507/bp.2015.066</ArticleId>
            <ArticleId IdType="pubmed">26740047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishii K, Kubo KI, Nakajima K. Reelin and neuropsychiatric disorders. Frontiers Cell Neurosci. 2016;10:229. doi: 10.3389/fncel.2016.00229.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2016.00229</ArticleId>
            <ArticleId IdType="pmc">PMC5067484</ArticleId>
            <ArticleId IdType="pubmed">27803648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oblak AL, Gibbs TT, Blatt GJ. Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in autism. J Neurochem. 2010;114:1414–1423.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2923229</ArticleId>
            <ArticleId IdType="pubmed">20557420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Notwell JH, Heavner WE, Darbandi SF, et al.  TBR1 regulates autism risk genes in the developing neocortex. Genome Res. 2016;26:1013–1022. doi: 10.1101/gr.203612.115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gr.203612.115</ArticleId>
            <ArticleId IdType="pmc">PMC4971772</ArticleId>
            <ArticleId IdType="pubmed">27325115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanashima C, Toma K. Switching modes in corticogenesis: mechanisms of neuronal subtype transitions and integration in the cerebral cortex. Front Neurosci. 2015;9:274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4531338</ArticleId>
            <ArticleId IdType="pubmed">26321900</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ichtchenko K, Hata Y, Nguyen T, et al.  Neuroligin 1: a splice site-specific ligand for β-neurexins. Cell. 1995;81:435–443. doi: 10.1016/0092-8674(95)90396-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0092-8674(95)90396-8</ArticleId>
            <ArticleId IdType="pubmed">7736595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J, Yu S, Fu Y, Li X. Synaptic proteins and receptors defects in autism spectrum disorders. Front Cell Neurosci. 2014;8:276. doi: 10.3389/fncel.2014.00276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2014.00276</ArticleId>
            <ArticleId IdType="pmc">PMC4161164</ArticleId>
            <ArticleId IdType="pubmed">25309321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Williams E, Casanova M. Above genetics: lessons from cerebral development in autism. Transl Neurosci. 2011;2:106–120. doi: 10.2478/s13380-011-0016-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2478/s13380-011-0016-3</ArticleId>
            <ArticleId IdType="pmc">PMC3331673</ArticleId>
            <ArticleId IdType="pubmed">22523638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wisniewska MB. Physiological role of β-catenin/TCF signaling in neurons of the adult brain. Neurochem Res. 2013;38:1144–1155. doi: 10.1007/s11064-013-0980-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11064-013-0980-9</ArticleId>
            <ArticleId IdType="pmc">PMC3653035</ArticleId>
            <ArticleId IdType="pubmed">23377854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feliciano DM, Su T, Lopez J, Platel JC, Bordey A. Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J Clin Invest. 2011;121:1596–1607. doi: 10.1172/JCI44909.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI44909</ArticleId>
            <ArticleId IdType="pmc">PMC3069783</ArticleId>
            <ArticleId IdType="pubmed">21403402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Won H, Mah W, Kim E. Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Molecu Neurosci. 2013;6:19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3733014</ArticleId>
            <ArticleId IdType="pubmed">23935565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lahiri DK, Sokol DK, Erickson C, Ray B, Ho CY, Maloney B. Autism as early neurodevelopmental disorder: evidence for an sAPPα-mediated anabolic pathway. Front Cell Neuro. 2013;7:94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3689023</ArticleId>
            <ArticleId IdType="pubmed">23801940</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin TV, Hsieh L, Kimura T, Malone TJ, Bordey A. Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration. Proc Natl Acad Sci U S A. 2016;113:11330–11335. doi: 10.1073/pnas.1605740113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1605740113</ArticleId>
            <ArticleId IdType="pmc">PMC5056085</ArticleId>
            <ArticleId IdType="pubmed">27647922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oron O, Elliott E. Delineating the Common Biological Pathways Perturbed by ASD’s Genetic Etiology: Lessons from Network-Based Studies. Int J Molecu Sci. 2017;18:828. doi: 10.3390/ijms18040828.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18040828</ArticleId>
            <ArticleId IdType="pmc">PMC5412412</ArticleId>
            <ArticleId IdType="pubmed">28420080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Noelanders R, Vleminckx K. How Wnt signaling builds the brain: bridging development and disease. Neuroscientist. 2017;23:314–329. doi: 10.1177/1073858416667270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1073858416667270</ArticleId>
            <ArticleId IdType="pubmed">27624848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung NH, Janzarik WG, Delvendahl I, et al.  Impaired induction of long‐term potentiation‐like plasticity in patients with high‐functioning autism and Asperger syndrome. Dev Med Child Neurol. 2013;55:83–89. doi: 10.1111/dmcn.12012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/dmcn.12012</ArticleId>
            <ArticleId IdType="pubmed">23157428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wen Y, Alshikho MJ, Herbert MR. Pathway network analyses for autism reveal multisystem involvement, major overlaps with other diseases and convergence upon MAPK and calcium signaling. PLoS One. 2016;11:e0153329. doi: 10.1371/journal.pone.0153329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0153329</ArticleId>
            <ArticleId IdType="pmc">PMC4824422</ArticleId>
            <ArticleId IdType="pubmed">27055244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Loghlen A, Perez-Morgado MI, Salinas M, Martin ME. N-acetyl-cysteine abolishes hydrogen peroxide-induced modification of eukaryotic initiation factor 4F activity via distinct signalling pathways. Cell Signal. 2006;18:21–31. doi: 10.1016/j.cellsig.2005.03.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2005.03.013</ArticleId>
            <ArticleId IdType="pubmed">15907373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122:3589–3594. doi: 10.1242/jcs.051011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.051011</ArticleId>
            <ArticleId IdType="pmc">PMC2758797</ArticleId>
            <ArticleId IdType="pubmed">19812304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murugan AK, Alzahrani A, Xing M. Mutations in critical domains confer the human mTOR gene strong tumorigenicity. J Bio Chem. 2013;288:6511–6521. doi: 10.1074/jbc.M112.399485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.399485</ArticleId>
            <ArticleId IdType="pmc">PMC3585084</ArticleId>
            <ArticleId IdType="pubmed">23322780</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conciatori F, Ciuffreda L, Bazzichetto C, et al.  mTOR cross-talk in cancer and potential for combination therapy. Cancers. 2018;10:23. doi: 10.3390/cancers10010023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cancers10010023</ArticleId>
            <ArticleId IdType="pmc">PMC5789373</ArticleId>
            <ArticleId IdType="pubmed">29351204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Audet-Walsh É, Dufour CR, Yee T, et al.  Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer. Genes Dev. 2017;31:1228–1242. doi: 10.1101/gad.299958.117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.299958.117</ArticleId>
            <ArticleId IdType="pmc">PMC5558925</ArticleId>
            <ArticleId IdType="pubmed">28724614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu J, Pham CG, Albanese SK, et al.  Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin. J Clin Invest. 2016;126:3526–3540. doi: 10.1172/JCI86120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI86120</ArticleId>
            <ArticleId IdType="pmc">PMC5004947</ArticleId>
            <ArticleId IdType="pubmed">27482884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis NM, Sokolosky M, Stadelman K, et al.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. Oncotarget. 2014;5:4603. doi: 10.18632/oncotarget.2209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.2209</ArticleId>
            <ArticleId IdType="pmc">PMC4148087</ArticleId>
            <ArticleId IdType="pubmed">25051360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Samidurai A, Kukreja RC, Das A. Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases. Oxid Med Cell Longev. 2018;2018;23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6165581</ArticleId>
            <ArticleId IdType="pubmed">30305865</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viana SD, Reis F, Alves R. Therapeutic Use of mTOR Inhibitors in Renal Diseases: Advances, Drawbacks, and Challenges. Oxid Med Cell Longev. 20182018 doi: 10.1155/2018/3693625. 3693625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2018/3693625</ArticleId>
            <ArticleId IdType="pmc">PMC6231362</ArticleId>
            <ArticleId IdType="pubmed">30510618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawrence J, Nho R. The role of the mammalian target of rapamycin (mTOR) in pulmonary fibrosis. Inter J Mol Sci. 2018;19:778. doi: 10.3390/ijms19030778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms19030778</ArticleId>
            <ArticleId IdType="pmc">PMC5877639</ArticleId>
            <ArticleId IdType="pubmed">29518028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chau GC, Im DU, Kang TM, et al.  mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress. J Cell Biol. 2017;216:2091–2105. doi: 10.1083/jcb.201701085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201701085</ArticleId>
            <ArticleId IdType="pmc">PMC5496625</ArticleId>
            <ArticleId IdType="pubmed">28606928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Striano P, Zara F. Genetics: mutations in mTOR pathway linked to megalencephaly syndromes. Nat Rev Neurol. 2012;8(10):542. doi: 10.1038/nrneurol.2012.178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneurol.2012.178</ArticleId>
            <ArticleId IdType="pubmed">22907262</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirzaa GM, Campbell CD, Solovieff N, et al.  Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol. 2016;73:836–845. doi: 10.1001/jamaneurol.2016.0363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamaneurol.2016.0363</ArticleId>
            <ArticleId IdType="pmc">PMC4979321</ArticleId>
            <ArticleId IdType="pubmed">27159400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JH, Huynh M, Silhavy J, et al.  De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet. 2012;44:941. doi: 10.1038/ng.2329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.2329</ArticleId>
            <ArticleId IdType="pmc">PMC4417942</ArticleId>
            <ArticleId IdType="pubmed">22729223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panner A, James CD, Berger MS, Pieper RO. mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol. 2005;25:8809–8823. doi: 10.1128/MCB.25.20.8809-8823.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.25.20.8809-8823.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1265779</ArticleId>
            <ArticleId IdType="pubmed">16199861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim JS, Kim W, Kang HC, et al.  Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med. 2015;21(4):395. doi: 10.1038/nm.3824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3824</ArticleId>
            <ArticleId IdType="pubmed">25799227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ryskalin L, Lazzeri G, Flaibani M, et al.  mTOR-dependent cell proliferation in the brain. Biomed Res Int. 2017;2017;14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5702949</ArticleId>
            <ArticleId IdType="pubmed">29259984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa-Mattioli M, Monteggia LM. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci. 2013;16:1537–1543. doi: 10.1038/nn.3546.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn.3546</ArticleId>
            <ArticleId IdType="pubmed">24165680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee HK, Kwon B, Lemere CA, et al.  mTORC2 (Rictor) in Alzheimer’s disease and reversal of amyloid-β expression-induced insulin resistance and toxicity in rat primary cortical neurons. J Alz Dis. 2017;56:1015–1036. doi: 10.3233/JAD-161029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/JAD-161029</ArticleId>
            <ArticleId IdType="pmc">PMC5577393</ArticleId>
            <ArticleId IdType="pubmed">28035937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dan HC, Ebbs A, Pasparakis M, Van Dyke T, Basseres DS, Baldwin AS. Akt-dependent activation of mTORC1 Involves phosphorylation of mTOR by IKKalpha. J Bio Chem. 2014;289:25227–25240. doi: 10.1074/jbc.M114.554881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.554881</ArticleId>
            <ArticleId IdType="pmc">PMC4155685</ArticleId>
            <ArticleId IdType="pubmed">24990947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takei N, Nawa H. mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neuro. 2014;7:28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4005960</ArticleId>
            <ArticleId IdType="pubmed">24795562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Winden KD, Ebrahimi-Fakhari D, Sahin M. Abnormal mTOR activation in autism. Annu Rev of Neuro. 2018;41:1–23. doi: 10.1146/annurev-neuro-080317-061747.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-neuro-080317-061747</ArticleId>
            <ArticleId IdType="pubmed">29490194</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muranen T, Selfors LM, Worster DT, et al.  Inhibition of PI3K/mTOR leads to adaptive resistance in matrixattached cancer cells. Cancer cell. 2012;21:227–239. doi: 10.1016/j.ccr.2011.12.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccr.2011.12.024</ArticleId>
            <ArticleId IdType="pmc">PMC3297962</ArticleId>
            <ArticleId IdType="pubmed">22340595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sawicka K, Zukin RS. Dysregulation of mTOR signaling in neuropsychiatric disorders: therapeutic implications. Neuropsychopharma. 2012;37:305. doi: 10.1038/npp.2011.210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/npp.2011.210</ArticleId>
            <ArticleId IdType="pmc">PMC3238083</ArticleId>
            <ArticleId IdType="pubmed">22157871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharma A, Hoeffer CA, Takayasu Y, et al.  Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci. 2010;30:694–702. doi: 10.1523/JNEUROSCI.3696-09.2010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3696-09.2010</ArticleId>
            <ArticleId IdType="pmc">PMC3665010</ArticleId>
            <ArticleId IdType="pubmed">20071534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun J, Liu Y, Moreno S, Baudry M, Bi X. Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function. J Neurosci. 2015;35:4706–4718. doi: 10.1523/JNEUROSCI.4276-14.2015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.4276-14.2015</ArticleId>
            <ArticleId IdType="pmc">PMC4363395</ArticleId>
            <ArticleId IdType="pubmed">25788687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piven J, Elison JT, Zylka MJ. Toward a conceptual framework for early brain and behavior development in autism. Mol psych. 2017;22:1385. doi: 10.1038/mp.2017.131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2017.131</ArticleId>
            <ArticleId IdType="pmc">PMC5621737</ArticleId>
            <ArticleId IdType="pubmed">28937691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84:275–291. doi: 10.1016/j.neuron.2014.09.034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.09.034</ArticleId>
            <ArticleId IdType="pmc">PMC4223653</ArticleId>
            <ArticleId IdType="pubmed">25374355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nicolini C, Fahnestock M. The valproic acid-induced rodent model of autism. Exper Neuro. 2018;299:217–227. doi: 10.1016/j.expneurol.2017.04.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.expneurol.2017.04.017</ArticleId>
            <ArticleId IdType="pubmed">28472621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Campanac E, Cheung HH, et al.  Idiopathic autism: cellular and molecular phenotypes in pluripotent stem cell-derived neurons. Mol Neurobiol. 2017;54:4507–4523. doi: 10.1007/s12035-016-9961-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-016-9961-8</ArticleId>
            <ArticleId IdType="pmc">PMC5199629</ArticleId>
            <ArticleId IdType="pubmed">27356918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyza KZ, Blanchard DC. The BTBR mouse model of idiopathic autism-Current view on mechanisms. Neurosci Biobehav Rev. 2017;76:99–110. doi: 10.1016/j.neubiorev.2016.12.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2016.12.037</ArticleId>
            <ArticleId IdType="pmc">PMC5403558</ArticleId>
            <ArticleId IdType="pubmed">28167097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onore C, Yang H, Van de Water J, Ashwood P. Dynamic Akt/mTOR signaling in children with autism spectrum disorder. Front Pediat. 2017;5:43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5350147</ArticleId>
            <ArticleId IdType="pubmed">28361047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Rosa BA, El Hokayem J, Artimovich E, et al.  Convergent Pathways in Idiopathic Autism Revealed by Time Course Transcriptomic Analysis of Patient-Derived Neurons. Scienti Rep. 2018;8:8423. doi: 10.1038/s41598-018-26495-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-26495-1</ArticleId>
            <ArticleId IdType="pmc">PMC5976773</ArticleId>
            <ArticleId IdType="pubmed">29849033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Showkat M, Beigh MA, Andrabi KI. mTOR signaling in protein translation regulation: implications in cancer genesis and therapeutic interventions. Mol Biol Int. 2014;2014;14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4258317</ArticleId>
            <ArticleId IdType="pubmed">25505994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kelleher RJ, III, Bear MF. The autistic neuron: troubled translation? Cell. 2008;135:401–406. doi: 10.1016/j.cell.2008.10.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2008.10.017</ArticleId>
            <ArticleId IdType="pubmed">18984149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dowling RJ, Topisirovic I, Alain T, et al.  mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science. 2010;328:1172–1176. doi: 10.1126/science.1187532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1187532</ArticleId>
            <ArticleId IdType="pmc">PMC2893390</ArticleId>
            <ArticleId IdType="pubmed">20508131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanne SM, Gerber AJ, Quirmbach LM, Sparrow SS, Cicchetti DV, Saulnier CA. The role of adaptive behavior in autism spectrum disorders: Implications for functional outcome. J Autism Dev Disord. 2011;41:1007–1018. doi: 10.1007/s10803-010-1126-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10803-010-1126-4</ArticleId>
            <ArticleId IdType="pubmed">21042872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jossé L, Xie J, Proud CG, Smales CM. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells. Biochem J. 2016;473:4651–4664. doi: 10.1042/BCJ20160845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BCJ20160845</ArticleId>
            <ArticleId IdType="pmc">PMC5147049</ArticleId>
            <ArticleId IdType="pubmed">27760840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jernigan CS, Goswami DB, Austin MC, et al.  The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2011;35:1774–1779. doi: 10.1016/j.pnpbp.2011.05.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pnpbp.2011.05.010</ArticleId>
            <ArticleId IdType="pmc">PMC3154612</ArticleId>
            <ArticleId IdType="pubmed">21635931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol. 2009;182:2786–2794. doi: 10.4049/jimmunol.0803484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0803484</ArticleId>
            <ArticleId IdType="pmc">PMC2648124</ArticleId>
            <ArticleId IdType="pubmed">19234173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shott RH, Appanah C, Grenier C, Tremblay G, Roucou X, Schang LM. Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic. PrP Virol J. 2014;11:175. doi: 10.1186/1743-422X-11-175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1743-422X-11-175</ArticleId>
            <ArticleId IdType="pmc">PMC4283144</ArticleId>
            <ArticleId IdType="pubmed">25280966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao R, Robinson B, Xu H. Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling. Neuron. 2013;79:712–724. doi: 10.1016/j.neuron.2013.06.026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2013.06.026</ArticleId>
            <ArticleId IdType="pmc">PMC3856944</ArticleId>
            <ArticleId IdType="pubmed">23972597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gkogkas CG, Khoutorsky A, Ran I, et al.  Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature. 2013;493:371. doi: 10.1038/nature11628.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11628</ArticleId>
            <ArticleId IdType="pmc">PMC4133997</ArticleId>
            <ArticleId IdType="pubmed">23172145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dennis MD, Kimball SR, Jefferson LS. Mechanistic target of rapamycin complex 1 (mTORC1)-mediated phosphorylation is governed by competition between substrates for interaction with raptor. J Bio Chem. 2013;288:10–19. doi: 10.1074/jbc.M112.402461.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.402461</ArticleId>
            <ArticleId IdType="pmc">PMC3537002</ArticleId>
            <ArticleId IdType="pubmed">23184952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao XF, Gartenhaus RB. Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma. Expert Opin Ther Targets. 2009;13:1085–1093. doi: 10.1517/14728220903103833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14728220903103833</ArticleId>
            <ArticleId IdType="pubmed">19614561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahrami BF, Ataie-Kachoie P, Pourgholami MH, Morris DL. p70 Ribosomal protein S6 kinase (Rps6kb1): an update. J Clin Pathol. 2014;12:1019–1025. doi: 10.1136/jclinpath-2014-202560.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jclinpath-2014-202560</ArticleId>
            <ArticleId IdType="pubmed">25100792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahrami F, Pourgholami MH, Mekkawy AH, Rufener L, Morris DL. Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway. Am J Can Res. 2014;4:558–571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4163620</ArticleId>
            <ArticleId IdType="pubmed">25232497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biever A, Valjent E, Puighermanal E. Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function. Front Mol Neuro. 2015;8:75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4679984</ArticleId>
            <ArticleId IdType="pubmed">26733799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwon CH, Luikart BW, Powell CM, et al.  Pten regulates neuronal arborization and social interaction in mice. Neuron. 2006;50:377–388. doi: 10.1016/j.neuron.2006.03.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2006.03.023</ArticleId>
            <ArticleId IdType="pmc">PMC3902853</ArticleId>
            <ArticleId IdType="pubmed">16675393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogawa S, Kwon CH, Zhou J, Koovakkattu D, Parada LF, Sinton CM. A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice. Brain Res. 2007;1168:112–123. doi: 10.1016/j.brainres.2007.06.074.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2007.06.074</ArticleId>
            <ArticleId IdType="pubmed">17706614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lafourcade CA, Lin TV, Feliciano DM, Zhang L, Hsieh LS, Bordey A. Rheb activation in subventricular zone progenitors leads to heterotopia, ectopic neuronal differentiation, and rapamycin-sensitive olfactory micronodules and dendrite hypertrophy of newborn neurons. J Neurosci. 2013;33:2419–2431. doi: 10.1523/JNEUROSCI.1840-12.2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1840-12.2013</ArticleId>
            <ArticleId IdType="pmc">PMC3711634</ArticleId>
            <ArticleId IdType="pubmed">23392671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci. 2005;8:1727. doi: 10.1038/nn1566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn1566</ArticleId>
            <ArticleId IdType="pubmed">16286931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomanetz V, Angliker N, Cloëtta D, et al.  Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J Cell Biol. 2013;201:293–308. doi: 10.1083/jcb.201205030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201205030</ArticleId>
            <ArticleId IdType="pmc">PMC3628512</ArticleId>
            <ArticleId IdType="pubmed">23569215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weston MC, Chen H, Swann JW. Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures. Front Mol Neurosci. 2014;7:1. doi: 10.3389/fnmol.2014.00001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnmol.2014.00001</ArticleId>
            <ArticleId IdType="pmc">PMC3922082</ArticleId>
            <ArticleId IdType="pubmed">24574959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi YJ, Di Nardo A, Kramvis I, et al.  Tuberous sclerosis complex proteins control axon formation. Genes Dev. 2008;22:2485–2495. doi: 10.1101/gad.1685008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gad.1685008</ArticleId>
            <ArticleId IdType="pmc">PMC2546692</ArticleId>
            <ArticleId IdType="pubmed">18794346</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
